Under Obamacare, health insurers must cover the children of policy holders up to 26 years old. Obviously, that mandated coverage is a significant new expense.

Also, Obamacare eliminated coverage caps. Previously many health insurance policies had lifetime caps for coverage, meaning that there was a top end to the amount your policy would pay out. Now, nobody likes the idea of a cap, but the truth is that it held costs down. Eliminating increases cost of coverage, and thus increases premium payments made by employers and employees.

And, finally, there's the "free" screening and preventative care that insurers are required to cover. Only, those things aren't free. Covering them costs the insurance company money, and they pass that cost off to premium payers.

A severe shortage of drugs for chemotherapy, infections and other serious ailments is endangering patients and forcing hospitals to buy life-saving medications from secondary suppliers at huge markups because they can't get them any other way.

The shortages, mainly involving widely-used generic injected drugs that ordinarily are cheap, have been delaying surgeries and cancer treatments, leaving patients in unnecessary pain and forcing hospitals to give less effective treatments. That's resulted in complications and longer hospital stays.

Companies abandoning the injected generic drug market because the profit margins are slim. Producing these sterile medicines is far more complicated and expensive than stamping out pills, and it can take about three weeks to produce a batch.

Only a half-dozen companies make the vast majority of injected generics. Even if other companies wanted to begin making a generic drug in short supply, they're discouraged by the lengthy, expensive process of setting up new manufacturing lines and getting FDA approval.